• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Certara, Inc. - Common Stock (NQ:CERT)

9.330 -0.340 (-3.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Certara, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Healthcare AI Exits Pilot Phase, Enters Production Deployment
December 12, 2025
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
Certara Appoints Jon Resnick as Chief Executive Officer
December 11, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Reports Third Quarter 2025 Financial Results
November 06, 2025
Updates Full Year 2025 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara Automates Scientific Workflows with Phoenix® Cloud
November 04, 2025
New cloud capabilities cut time to create Tables, Figures, and Listings by 50% 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
October 31, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Expands Biosimulation Market with AI-Driven QSP Platform
October 30, 2025
Certara IQ™ integrates AI and biosimulation to accelerate R&D productivity, reduce risk, and deepen understanding of novel and complex therapies 
From Certara
Via GlobeNewswire
News headline image
Certara Scientists are Among the Topmost Cited Biopharma Researchers
October 20, 2025
Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025 
From Certara
Via GlobeNewswire
News headline image
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
October 10, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
September 04, 2025
Solution delivers a 50% reduction in time spent drafting mapping specifications, according to internal measurements 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
September 02, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Reports Second Quarter 2025 Financial Results
August 06, 2025
Reiterates Full Year 2025 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
August 04, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
July 31, 2025
Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time to market in drug discovery and development 
From Certara
Via GlobeNewswire
News headline image
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
July 09, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Announces Expansion of Clinical Technology Collaboration with Merck
July 08, 2025
Expands use of the Certara Pinnacle 21® (P21) enterprise software platform to optimize clinical data flows for speed and quality 
From Certara
Via GlobeNewswire
News headline image
Certara Reports First Quarter 2025 Financial Results
May 05, 2025
Reiterates Full Year 2025 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
April 29, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
April 14, 2025
New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies 
From Certara
Via GlobeNewswire
News headline image
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
April 14, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
April 01, 2025
Updates strengthen Certara’s position as a leader of PBPK modeling in drug development to advance regulatory decision-making 
From Certara
Via GlobeNewswire
News headline image
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
March 05, 2025
McKemey joins Certara to accelerate growth of its strategic drug development solutions 
From Certara
Via GlobeNewswire
News headline image
Certara Reports Fourth Quarter 2024 Financial Results
February 26, 2025
Issues Full Year 2025 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
January 29, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 15, 2025
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 02, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Showcases 2024 Research Wins With Over 100 Papers Published
December 02, 2024
The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list 
From Certara
Via GlobeNewswire
News headline image
Certara Reports Third Quarter 2024 Financial Results
November 06, 2024
Updates Full Year 2024 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in the Stephens Annual Investment Conference
October 28, 2024
From Certara
Via GlobeNewswire
News headline image
Certara Appoints John Reynders as New Independent Board Member
October 16, 2024
From Certara
Via GlobeNewswire
News headline image
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
From MaxCyte, Inc
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap